Leading international law firm Herbert Smith Freehills Kramer has advised Nanomi B.V., a Dutch subsidiary of Lupin Limited, on the acquisition of VISUfarma B.V. (VISUfarma), a portfolio company of global healthcare specialist investor GHO Capital Partners LLP (GHO).
The acquisition of VISUfarma aligns with Lupin's strategy to expand its European business and footprint and to advance the company's global specialty franchise. The transaction will also allow Lupin to tap into the attractive ophthalmology market and provide market expansion opportunities, direct presence and further business diversification across major European countries, including Italy, the UK, Spain, Germany and France.
Lupin is a global, multinational pharmaceutical company headquartered in Mumbai, India. Lupin develops and commercialises a wide range of branded and generic formulations, biotechnology products and APIs in over 100 markets including the USA, India, South Africa and across Asia Pacific, Latin America, Middle East regions and Europe.
The Legal team at Lupin was led by Thomas Ghignone, Senior Vice President, Legal, and Ilana Pearl, Executive Director, Legal Counsel. The Herbert Smith Freehills Kramer team was led by Corporate partner Alan Montgomery and senior associate Faria Ali, supported by associates Alex Sergunin, Trevor Lowe and Shereen Goh and trainees Zhiwan Rong and Guto Tejid, specialist teams in in employment, IP, Tax, data protection, insurance, real estate, finance and regulatory and teams in Milan, Frankfurt, Madrid and Paris (led by Augusto Santoro, Laura Orlando, Christian Johnen, Guillermo Uriarte and Cyril Boulignat). In addition, Stibbe advised on Dutch law matters and QLT, led by Francesco D'Amora, advised on Italian employment matters.
Senior Associate Faria Ali said: "We are immensely proud to have advised long-standing client Lupin on yet another successful transaction and one which establishes Lupin's ophthalmology portfolio to expand the company's reach across Europe."